Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
The funds will be used to scale up existing operations and launch new products
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Flipkart also announced its foray into the healthcare sector through the launch of Flipkart Health+
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
Subscribe To Our Newsletter & Stay Updated
